LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3500
0.00 (0.00%)
May 21, 2026, 10:16 AM EST
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 42.43 million as of May 21, 2026. Its market cap has increased by 9.62% in one year.
Market Cap
42.43M
Enterprise Value
64.03M
Revenue
26.80M
Ranking
n/a
PE Ratio
15.43
Stock Price
0.35
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 42.43M, a decrease of -31.20%. That is a compound annual growth rate of -10.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 42.43M | - |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decibel Cannabis Company | 72.13M |
| Planet 13 Holdings | 59.15M |
| Leef Brands | 59.09M |
| BioNxt Solutions | 55.88M |
| C21 Investments | 40.16M |
| ZYUS Life Sciences | 39.86M |
| Mountain Valley MD Holdings | 38.85M |
| MediPharm Labs | 36.11M |